Anastasia Sarikidi

SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia

P. Raab, S. Petri, M. Wattjes, 2020, Journal of Neurology.

Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis

S. Petri, S. Klöss, U. Köhl, 2019, Journal of tissue engineering and regenerative medicine.

Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS

A. Ganser, S. Petri, C. Falk, 2022, Biomedicines.

Isoform‐selective as opposed to complete depletion of fibroblast growth factor 2 (FGF‐2) has no major impact on survival and gene expression in SOD1G93A amyotrophic lateral sclerosis mice

S. Petri, C. Grothe, M. Ettcheto, 2019, The European journal of neuroscience.

Characterizing the multiple roles of FGF‐2 in SOD1G93A ALS mice in vivo and in vitro

S. Petri, C. Grothe, F. Wegner, 2018, Journal of cellular physiology.

Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis

M. Stangel, P. Bronzlik, R. Pul, 2017, International journal of molecular sciences.

McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity

P. Raab, M. Stangel, P. Bronzlik, 2016, International journal of molecular sciences.

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.

S. Petri, A. Ludolph, J. Grosskreutz, 2022, JAMA neurology.